In this context, a thorium-227 conjugated Ab, BAY2287411, was developed and evaluated in patient-derived xenograft models of various MSLN-overexpressing malignancies, including breast, colorectal, lung, ovarian, and pancreatic cancers. This evidence concerns the gene MSLN and pancreatic neoplasm.